$2.57T
Total marketcap
$176.23B
Total volume
BTC 49.95%     ETH 15.88%
Dominance

Day One Biopharmaceuticals DAWN Stock

13.93 USD {{ price }} -3.196665% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
1.22B USD
LOW - HIGH [24H]
13.91 - 14.59 USD
VOLUME [24H]
512.01K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.37 USD

Day One Biopharmaceuticals Price Chart

Day One Biopharmaceuticals DAWN Financial and Trading Overview

Day One Biopharmaceuticals stock price 13.93 USD
Previous Close 13.47 USD
Open 13.44 USD
Bid 0 USD x 900
Ask 0 USD x 900
Day's Range 12.86 - 13.48 USD
52 Week Range 10.84 - 28.35 USD
Volume 1.37M USD
Avg. Volume 1.2M USD
Market Cap 1.14B USD
Beta (5Y Monthly) -2.082746
PE Ratio (TTM) N/A
EPS (TTM) -2.37 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 40.67 USD

DAWN Valuation Measures

Enterprise Value 673.56M USD
Trailing P/E N/A
Forward P/E -6.441177
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 3.218222
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -4.083

Trading Information

Day One Biopharmaceuticals Stock Price History

Beta (5Y Monthly) -2.082746
52-Week Change -16.78%
S&P500 52-Week Change 20.43%
52 Week High 28.35 USD
52 Week Low 10.84 USD
50-Day Moving Average 13.15 USD
200-Day Moving Average 18.44 USD

DAWN Share Statistics

Avg. Volume (3 month) 1.2M USD
Avg. Daily Volume (10-Days) 2.44M USD
Shares Outstanding 86.84M
Float 46.89M
Short Ratio 10.72
% Held by Insiders 29.28%
% Held by Institutions 82.30%
Shares Short 10M
Short % of Float 24.05%
Short % of Shares Outstanding 13.58%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -34.88%
Return on Equity (ttm) -56.0080%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -164952992 USD
Net Income Avi to Common (ttm) -156827008 USD
Diluted EPS (ttm) -2.45
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 318.18M USD
Total Cash Per Share (mrq) 4.33 USD
Total Debt (mrq) 717K USD
Total Debt/Equity (mrq) 0.24 USD
Current Ratio (mrq) 14.11
Book Value Per Share (mrq) 4.083

Cash Flow Statement

Operating Cash Flow (ttm) -114296000 USD
Levered Free Cash Flow (ttm) -57264000 USD

Profile of Day One Biopharmaceuticals

Country United States
State CA
City Brisbane
Address 2000 Sierra Point Parkway
ZIP 94005
Phone 650 484 0899
Website https://dayonebio.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 125

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

Q&A For Day One Biopharmaceuticals Stock

What is a current DAWN stock price?

Day One Biopharmaceuticals DAWN stock price today per share is 13.93 USD.

How to purchase Day One Biopharmaceuticals stock?

You can buy DAWN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Day One Biopharmaceuticals?

The stock symbol or ticker of Day One Biopharmaceuticals is DAWN.

Which industry does the Day One Biopharmaceuticals company belong to?

The Day One Biopharmaceuticals industry is Biotechnology.

How many shares does Day One Biopharmaceuticals have in circulation?

The max supply of Day One Biopharmaceuticals shares is 87.38M.

What is Day One Biopharmaceuticals Price to Earnings Ratio (PE Ratio)?

Day One Biopharmaceuticals PE Ratio is now.

What was Day One Biopharmaceuticals earnings per share over the trailing 12 months (TTM)?

Day One Biopharmaceuticals EPS is -2.37 USD over the trailing 12 months.

Which sector does the Day One Biopharmaceuticals company belong to?

The Day One Biopharmaceuticals sector is Healthcare.

Day One Biopharmaceuticals DAWN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD